HIGH IMPORTANCE! MUST READ! House Committee on Energy and Commerce Counterfeit Drugs: Fightling Illegal Supply Chains Hearing Held on February 27, 2014 Video, Agenda and Written Testimony

Thursday, February 27, 2014 - 10:00am

Oversight and Investigations

2322 Rayburn

Background Documents and Information: 

Hearing Notice
Background Memo

-

Opening Statements: 

Oversight and Investigations Subcommittee Chairman Tim Murphy

Witnesses: 

Panel I

Howard Sklamberg, J.D.

• Deputy Commissioner for Global Regulatory Operations and Policy
• Food and Drug Administration (FDA)
• Witness Testimony (Truth in Testimony and CV)

Lev Kubiak

• Director
• National Intellectual Property Rights Coordination Center
• Department of Homeland Security
• Immigration and Customs Enforcement (ICE)
• Witness Testimony (Truth in Testimony CV)

Panel II

Marcia Crosse, Ph.D.

• Director
• Health Care
• U.S. Government Accountability Office
• Witness Testimony (Truth in Testimony and CV)

Prashant Yadav, Ph.D., M.B.A.

• Director of Health Care Research Initiative
• Director of the William Davidson Institute
• University of Michigan
• Witness Testimony (Truth in Testimony and CV)

John P. Clark

• Vice President and Chief Security Officer
• Global Security, Compliance Division
• Pfizer Inc.
• Witness Testimony (Truth in Testimony and CV)

Jean-Luc Moreau

• Global Head of Product Security
• Novartis Corporation
• Witness Testimony (Truth in Testimony and CV)

Bruce Longbottom, J.D.

• Assistant General Counsel
• Eli Lilly and Company
• Witness Testimony (Truth in Testimony and CV)

Elizabeth Jungman, J.D.M.P.H.,

• Director
• Drug Safety and Innovation
• Pew Charitable Trusts
• Witness Testimony (Truth in Testimony and CV)

- See more at: http://energycommerce.house.gov/hearing/counterfeit-drugs-fighting-illegal-supply-chains#sthash.qtNlOs3O.dpuf